561 related articles for article (PubMed ID: 35351998)
1. The emerging role of mass spectrometry-based proteomics in drug discovery.
Meissner F; Geddes-McAlister J; Mann M; Bantscheff M
Nat Rev Drug Discov; 2022 Sep; 21(9):637-654. PubMed ID: 35351998
[TBL] [Abstract][Full Text] [Related]
2. Mass Spectrometry-Based Chemical Proteomics for Drug Target Discoveries.
Fedorov II; Lineva VI; Tarasova IA; Gorshkov MV
Biochemistry (Mosc); 2022 Sep; 87(9):983-994. PubMed ID: 36180990
[TBL] [Abstract][Full Text] [Related]
3. Chemoproteomic approaches to drug target identification and drug profiling.
Bantscheff M; Drewes G
Bioorg Med Chem; 2012 Mar; 20(6):1973-8. PubMed ID: 22130419
[TBL] [Abstract][Full Text] [Related]
4. Chemoproteomics and Chemical Probes for Target Discovery.
Drewes G; Knapp S
Trends Biotechnol; 2018 Dec; 36(12):1275-1286. PubMed ID: 30017093
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry methods to study protein-metabolite interactions.
Guo H; Peng H; Emili A
Expert Opin Drug Discov; 2017 Dec; 12(12):1271-1280. PubMed ID: 28933205
[TBL] [Abstract][Full Text] [Related]
6. Target identification with quantitative activity based protein profiling (ABPP).
Chen X; Wong YK; Wang J; Zhang J; Lee YM; Shen HM; Lin Q; Hua ZC
Proteomics; 2017 Feb; 17(3-4):. PubMed ID: 27723264
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of molecular targets of natural products by mass spectrometry.
Cheng KW; Wong CC; Wang M; He QY; Chen F
Mass Spectrom Rev; 2010; 29(1):126-55. PubMed ID: 19319922
[TBL] [Abstract][Full Text] [Related]
8. Epigenetic drug target deconvolution by mass spectrometry-based technologies.
Noberini R; Bonaldi T
Nat Struct Mol Biol; 2019 Oct; 26(10):854-857. PubMed ID: 31582842
[TBL] [Abstract][Full Text] [Related]
9. Measurement and utilization of the proteomic reactivity by mass spectrometry.
Punzalan C; Wang L; Bajrami B; Yao X
Mass Spectrom Rev; 2024; 43(1):166-192. PubMed ID: 36924435
[TBL] [Abstract][Full Text] [Related]
10. Mesopore-assisted profiling strategies in clinical proteomics for drug/target discovery.
Savino R; Terracciano R
Drug Discov Today; 2012 Feb; 17(3-4):143-52. PubMed ID: 22016086
[TBL] [Abstract][Full Text] [Related]
11. Stability-based approaches in chemoproteomics.
George AL; Dueñas ME; Marín-Rubio JL; Trost M
Expert Rev Mol Med; 2024 Apr; 26():e6. PubMed ID: 38604802
[TBL] [Abstract][Full Text] [Related]
12. Methods and Algorithms for Quantitative Proteomics by Mass Spectrometry.
Matthiesen R; Carvalho AS
Methods Mol Biol; 2020; 2051():161-197. PubMed ID: 31552629
[TBL] [Abstract][Full Text] [Related]
13. [Recent advances in protein precipitation-based methods for drug-target screening].
Liu T; Qin WJ; Yang HJ
Se Pu; 2024 Jul; 42(7):613-622. PubMed ID: 38966970
[TBL] [Abstract][Full Text] [Related]
14. The Vital Role of Proteomics in Characterizing Novel Protein Degraders.
Zhang AX; Cassidy K; Dahl G; Moreau K; Pachl F; Zuhl AM
SLAS Discov; 2021 Apr; 26(4):518-523. PubMed ID: 33615886
[TBL] [Abstract][Full Text] [Related]
15. Chemical proteomics and its impact on the drug discovery process.
Miao Q; Zhang CC; Kast J
Expert Rev Proteomics; 2012 Jun; 9(3):281-91. PubMed ID: 22809207
[TBL] [Abstract][Full Text] [Related]
16. Proteomics in Drug Development: The Dawn of a New Era?
Frantzi M; Latosinska A; Mischak H
Proteomics Clin Appl; 2019 Mar; 13(2):e1800087. PubMed ID: 30724014
[TBL] [Abstract][Full Text] [Related]
17. Proteomics by mass spectrometry: approaches, advances, and applications.
Yates JR; Ruse CI; Nakorchevsky A
Annu Rev Biomed Eng; 2009; 11():49-79. PubMed ID: 19400705
[TBL] [Abstract][Full Text] [Related]
18. Chemical proteomics: terra incognita for novel drug target profiling.
Huang F; Zhang B; Zhou S; Zhao X; Bian C; Wei Y
Chin J Cancer; 2012 Nov; 31(11):507-18. PubMed ID: 22640626
[TBL] [Abstract][Full Text] [Related]
19. The future of drug discovery: enabling technologies for enhancing lead characterization and profiling therapeutic potential.
Janero DR
Expert Opin Drug Discov; 2014 Aug; 9(8):847-58. PubMed ID: 24965547
[TBL] [Abstract][Full Text] [Related]
20. Mass spectrometry-based proteomics in the life sciences.
Lane CS
Cell Mol Life Sci; 2005 Apr; 62(7-8):848-69. PubMed ID: 15868409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
